Resveratrol prevents rapamycin-induced upregulation of autophagy and selectively induces apoptosis in TSC2-deficient cells
about
Therapeutic targeting of cellular metabolism in cells with hyperactive mTORC1: a paradigm shiftManagement of lymphangioleiomyomatosisResveratrol inhibits breast cancer stem-like cells and induces autophagy via suppressing Wnt/β-catenin signaling pathwayResveratrol protects vascular smooth muscle cells against high glucose-induced oxidative stress and cell proliferation in vitro.Phosphoproteomics reveals resveratrol-dependent inhibition of Akt/mTORC1/S6K1 signaling.Inhibition of mTOR reduce Stat3 and PAI related angiogenesis in salivary gland adenoid cystic carcinoma.The combination of rapamycin and resveratrol blocks autophagy and induces apoptosis in breast cancer cells.Effects of combining rapamycin and resveratrol on apoptosis and growth of TSC2-deficient xenograft tumors.Resveratrol attenuates neuronal autophagy and inflammatory injury by inhibiting the TLR4/NF-κB signaling pathway in experimental traumatic brain injury.ERRα Is a Marker of Tamoxifen Response and Survival in Triple-Negative Breast CancerResveratrol protects astrocytes against traumatic brain injury through inhibiting apoptotic and autophagic cell death.Recent Advances and Challenges of mTOR Inhibitors Use in the Treatment of Patients with Tuberous Sclerosis Complex.Resveratrol as a novel treatment for diseases with mTOR pathway hyperactivation.Combination of Rapamycin and Resveratrol for Treatment of Bladder Cancer.Tuberous sclerosis complex: From molecular biology to novel therapeutic approaches.Resveratrol inhibits NLRP3 inflammasome activation by preserving mitochondrial integrity and augmenting autophagy.Estrogen induces RAD51C expression and localization to sites of DNA damageBlackcurrant anthocyanins stimulated cholesterol transport via post-transcriptional induction of LDL receptor in Caco-2 cells.mTOR Signaling and Neural Stem Cells: The Tuberous Sclerosis Complex Model.The therapeutic potential of resveratrol: a review of clinical trials.
P2860
Q26999365-2CD3D987-939A-4DC0-9249-D46A1514505BQ28084725-A6281DB4-93F5-4C73-A107-6ACD3753FE9CQ28541242-CF19BA25-4FA0-4E3F-8908-1CD2B2F2C92AQ33893097-F5ECA4D6-7E02-4E86-91DF-5851E9B6768BQ34644442-59638B18-74C0-484E-96F1-E4B6A8674DF0Q34704903-6E9D3334-1664-45BC-ABCE-3035BDBA767DQ35819635-B6E7B260-E6E3-4004-8745-00B85D8F42FCQ36549186-E29E30C2-570A-4502-9DC9-A5FF99D5090FQ36684264-E91D119A-638C-4FE5-9519-E7FB09D13050Q36693175-C9B7DE27-2B6E-4DBE-8BD1-7C5628E0AC8CQ37680244-8684ADCE-D16F-41C3-9F82-E6EC7DC3C65FQ37721031-C518F89B-B90A-4A84-9937-FB88E5D25ECDQ38552040-5C64DF81-7760-46F2-8851-825833EFD54CQ38735342-9AA19458-B1FF-4564-AD81-49B9FDDD0BECQ38994919-26ED4E76-64FF-494A-AD0F-4BA068BB34DDQ41655355-57181605-C264-4173-8187-28713729D5A8Q42345398-F639F32D-4D52-45B7-B196-D5CAA3D4A399Q48110789-11CE84E7-BC10-45B5-8F90-89634B03BA50Q54978861-849B97E9-1635-4E7F-9B6A-5059AD06B448Q55151370-E3B8DA8C-AEEB-431F-97A3-47B873B653D6
P2860
Resveratrol prevents rapamycin-induced upregulation of autophagy and selectively induces apoptosis in TSC2-deficient cells
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Resveratrol prevents rapamycin ...... ptosis in TSC2-deficient cells
@en
Resveratrol prevents rapamycin ...... tosis in TSC2-deficient cells.
@nl
type
label
Resveratrol prevents rapamycin ...... ptosis in TSC2-deficient cells
@en
Resveratrol prevents rapamycin ...... tosis in TSC2-deficient cells.
@nl
prefLabel
Resveratrol prevents rapamycin ...... ptosis in TSC2-deficient cells
@en
Resveratrol prevents rapamycin ...... tosis in TSC2-deficient cells.
@nl
P2093
P2860
P356
P1433
P1476
Resveratrol prevents rapamycin ...... ptosis in TSC2-deficient cells
@en
P2093
Anya Alayev
Marina K Holz
Rose B Snyder
Sara Malka Berger
P2860
P304
P356
10.4161/CC.27355
P577
2013-12-04T00:00:00Z